Republicans and antiabortion activists have set their sights on restricting access to medication abortions as part of their agenda for the year ahead, a strategy reproductive rights advocates worried would crop up in the wake of Dobbs v. Jackson Women’s Health Organization . FDA faces a new lawsuit over its expedited approval process for mifepristone, as well as a petition urging the agency to require providers to handle fetal remains as medical waste. Both efforts could make it more challenging...